ARCH Venture Partners

ARCH Venture Partners

ARCH Venture Partners

ARCH invests primarily in companies co-founded with leading scientists andentrepreneurs, concentrating on bringing to market innovations
Type
B2b
Founded
1986
Follow us
Alexa global traffic share
Latest investments Show all
$51,000,000
Venture capital (Series A)
Walden Biosciences
$60,000,000
Venture capital (Series B)
Nutcracker Therapeutics
Team Size
10+
Employees
Geographical Focus
Past year's investments
  • 5 rounds in the past year
  • $322.7M deployed in total
  • $64.5M avg per round
Latest rounds
  • Walden Biosciences: Venture capital (Series A) ($51M)
  • Nutcracker Therapeutics: Venture capital (Series B) ($60M)
  • Singleron Biotechnologies: Venture capital (Series A) ($30M)